• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A plasma protein indistinguishable from ribosomal protein S19: conversion to a monocyte chemotactic factor by a factor XIIIa-catalyzed reaction on activated platelet membrane phosphatidylserine in association with blood coagulation.一种与血液凝固有关的、在活化血小板膜磷脂酰丝氨酸上由因子 XIIIa 催化反应产生的、与核糖体蛋白 S19 无法区分的血浆蛋白:向单核细胞趋化因子的转化。
Am J Pathol. 2010 Mar;176(3):1542-51. doi: 10.2353/ajpath.2010.090720. Epub 2010 Jan 21.
2
S19 ribosomal protein cross-linked dimer causes monocyte-predominant infiltration by means of molecular mimicry to complement C5a.S19核糖体蛋白交联二聚体通过分子模拟补体C5a导致以单核细胞为主的浸润。
Lab Invest. 1998 Dec;78(12):1615-23.
3
Apoptotic cells of an epithelial cell line, AsPC-1, release monocyte chemotactic S19 ribosomal protein dimer.上皮细胞系AsPC-1的凋亡细胞释放单核细胞趋化性S19核糖体蛋白二聚体。
J Biochem. 2001 Mar;129(3):445-54. doi: 10.1093/oxfordjournals.jbchem.a002876.
4
Maintenance of ribosomal protein S19 in plasma by complex formation with prothrombin.通过与凝血酶形成复合物来维持血浆中的核糖体蛋白 S19。
Eur J Haematol. 2011 May;86(5):436-41. doi: 10.1111/j.1600-0609.2011.01585.x. Epub 2011 Apr 1.
5
Switch moiety in agonist/antagonist dual effect of S19 ribosomal protein dimer on leukocyte chemotactic C5a receptor.S19核糖体蛋白二聚体对白细胞趋化性C5a受体激动剂/拮抗剂双重效应中的转换部分。
Am J Pathol. 2003 Apr;162(4):1381-8. doi: 10.1016/S0002-9440(10)63934-X.
6
Role of ribosomal protein S19-like plasma protein in blood coagulum resorption.核糖体蛋白 S19 样血浆蛋白在血凝块吸收中的作用。
Exp Mol Pathol. 2011 Feb;90(1):19-28. doi: 10.1016/j.yexmp.2010.11.008. Epub 2010 Nov 26.
7
The role of the ribosomal protein S19 C-terminus in altering the chemotaxis of leucocytes by causing functional differences in the C5a receptor response.核糖体蛋白 S19 C 末端在改变白细胞趋化性中的作用是通过引起 C5a 受体反应的功能差异来实现的。
J Biochem. 2011 Sep;150(3):271-7. doi: 10.1093/jb/mvr067. Epub 2011 May 25.
8
Agonist and antagonist dual effect of the cross-linked S19 ribosomal protein dimer in the C5a receptor-mediated respiratory burst reaction of phagocytic leukocytes.交联的S19核糖体蛋白二聚体在C5a受体介导的吞噬性白细胞呼吸爆发反应中的激动剂和拮抗剂双重作用。
Inflamm Res. 2005 Feb;54(2):82-90. doi: 10.1007/s00011-004-1327-4.
9
Identification of receptor-binding sites of monocyte chemotactic S19 ribosomal protein dimer.单核细胞趋化性S19核糖体蛋白二聚体受体结合位点的鉴定
Am J Pathol. 2001 Dec;159(6):2293-301. doi: 10.1016/S0002-9440(10)63079-9.
10
Guinea pig S19 ribosomal protein as precursor of C5a receptor-directed monocyte-selective leukocyte chemotactic factor.
Inflamm Res. 2004 Nov;53(11):623-30. doi: 10.1007/s00011-004-1302-0.

引用本文的文献

1
Immune Aging and How It Works for Inflammation and Fibrosis.免疫衰老及其在炎症和纤维化中的作用机制
Front Physiol. 2022 Jan 4;12:795508. doi: 10.3389/fphys.2021.795508. eCollection 2021.
2
Factor XIII-A: An Indispensable "Factor" in Haemostasis and Wound Healing.凝血因子 XIII-A:止血和伤口愈合中不可或缺的“因子”
Int J Mol Sci. 2021 Mar 17;22(6):3055. doi: 10.3390/ijms22063055.
3
RP S19 C-terminal peptide trimer acts as a C5a receptor antagonist.RP S19 C末端肽三聚体作为一种C5a受体拮抗剂。
Biochem Biophys Rep. 2016 May 10;7:70-76. doi: 10.1016/j.bbrep.2016.05.006. eCollection 2016 Sep.
4
Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps.慢性鼻-鼻窦炎伴鼻息肉患者中因子 XIII-A 的表达增加。
J Allergy Clin Immunol. 2013 Sep;132(3):584-592.e4. doi: 10.1016/j.jaci.2013.02.003. Epub 2013 Mar 28.
5
Dual functions of the C5a receptor as a connector for the K562 erythroblast-like cell-THP-1 macrophage-like cell island and as a sensor for the differentiation of the K562 erythroblast-like cell during haemin-induced erythropoiesis.C5a受体在血红素诱导的红细胞生成过程中,作为K562成红细胞样细胞-THP-1巨噬细胞样细胞岛的连接物以及K562成红细胞样细胞分化的传感器的双重功能。
Clin Dev Immunol. 2012;2012:187080. doi: 10.1155/2012/187080. Epub 2012 Dec 30.

本文引用的文献

1
Agonistic and antagonistic effects of C5a-chimera bearing S19 ribosomal protein tail portion on the C5a receptor of monocytes and neutrophils, respectively.分别携带S19核糖体蛋白尾部的C5a嵌合体对单核细胞和中性粒细胞的C5a受体的激动和拮抗作用。
J Biochem. 2008 Sep;144(3):371-81. doi: 10.1093/jb/mvn077. Epub 2008 May 31.
2
Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function.活化血小板的信号依赖性蛋白质合成:改变表型和功能的新途径。
Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):s17-24. doi: 10.1161/ATVBAHA.107.160218.
3
Phospholipid scramblases: an overview.磷脂翻转酶:概述
Arch Biochem Biophys. 2007 Jun 1;462(1):103-14. doi: 10.1016/j.abb.2007.04.002. Epub 2007 Apr 17.
4
Roles of the ribosomal protein S19 dimer and the C5a receptor in pathophysiological functions of phagocytic leukocytes.核糖体蛋白S19二聚体和C5a受体在吞噬性白细胞病理生理功能中的作用。
Pathol Int. 2007 Jan;57(1):1-11. doi: 10.1111/j.1440-1827.2007.02049.x.
5
Analysis of SAGE data in human platelets: features of the transcriptome in an anucleate cell.人类血小板中SAGE数据的分析:无核细胞中转录组的特征
Thromb Haemost. 2006 Apr;95(4):643-51.
6
Monocyte chemotactic S19 ribosomal protein dimer in atherosclerotic vascular lesion.动脉粥样硬化血管病变中的单核细胞趋化性S19核糖体蛋白二聚体
Virchows Arch. 2005 Oct;447(4):747-55. doi: 10.1007/s00428-005-0012-5. Epub 2005 Oct 19.
7
S19 ribosomal protein dimer augments metal-induced apoptosis in a mouse fibroblastic cell line by ligation of the C5a receptor.S19核糖体蛋白二聚体通过连接C5a受体增强金属诱导的小鼠成纤维细胞系凋亡。
J Cell Biochem. 2005 Feb 15;94(3):540-53. doi: 10.1002/jcb.20318.
8
Molecular complexes in the isolation and characterization of plasma lipoproteins.用于分离和鉴定血浆脂蛋白的分子复合物
J Lipid Res. 1961 Apr;2:110-34.
9
Identification of receptor-binding sites of monocyte chemotactic S19 ribosomal protein dimer.单核细胞趋化性S19核糖体蛋白二聚体受体结合位点的鉴定
Am J Pathol. 2001 Dec;159(6):2293-301. doi: 10.1016/S0002-9440(10)63079-9.
10
Recruitment of labelled monocytes by experimental venous thrombi.实验性静脉血栓对标记单核细胞的募集作用。
Thromb Haemost. 2001 Jun;85(6):1018-24.

一种与血液凝固有关的、在活化血小板膜磷脂酰丝氨酸上由因子 XIIIa 催化反应产生的、与核糖体蛋白 S19 无法区分的血浆蛋白:向单核细胞趋化因子的转化。

A plasma protein indistinguishable from ribosomal protein S19: conversion to a monocyte chemotactic factor by a factor XIIIa-catalyzed reaction on activated platelet membrane phosphatidylserine in association with blood coagulation.

机构信息

Department of Molecular Pathology, Faculty of Life Sciences, Kumamoto University, 2-2-1 Honjo, Kumamoto 860-0811, Japan.

出版信息

Am J Pathol. 2010 Mar;176(3):1542-51. doi: 10.2353/ajpath.2010.090720. Epub 2010 Jan 21.

DOI:10.2353/ajpath.2010.090720
PMID:20093496
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2832172/
Abstract

A monocyte-chemoattracting factor is generated during blood coagulation and during clotting of platelet-rich plasma. This chemotactic factor attracts monocytes as a ligand of the C5a receptor; however, it inhibits C5a-induced neutrophil chemotaxis as an apparent receptor antagonist. The curious dual function of the serum monocyte chemotactic factor resembles that of the cross-linked homodimer of ribosomal protein S19 (RP S19). Indeed, the inactive precursor of the monocyte chemotactic factor was present in plasma, and the precursor molecule and RP S19, as well as the active form and the RP S19 dimer, were indistinguishable in terms of immunological reactivity and molecular size. Coagulation factor XIIIa, plasma transglutaminase, and membrane phosphatidylserine on the activated platelets were required for conversion of the precursor to the active form. In addition, the precursor molecule in plasma could be replaced by wild-type recombinant RP S19 but not by mutant forms of it. These results indicate that a molecule indistinguishable from RP S19 was present in plasma, and that the RP S19-like molecule was converted to the active form by a transglutaminase-catalyzed reaction on a scaffold that included the phosphatidylserine-exposed platelet membrane.

摘要

在血液凝固和富含血小板的血浆凝结过程中会产生一种单核细胞趋化因子。这种趋化因子作为 C5a 受体的配体吸引单核细胞; 然而,它作为一种明显的受体拮抗剂抑制 C5a 诱导的中性粒细胞趋化。血清单核细胞趋化因子的这种奇特的双重功能类似于核糖体蛋白 S19 (RP S19) 的交联同源二聚体。事实上,单核细胞趋化因子的无活性前体存在于血浆中,并且前体分子和 RP S19 以及活性形式和 RP S19 二聚体在免疫反应性和分子大小方面是不可区分的。凝血因子 XIIIa、血浆转谷氨酰胺酶和活化血小板上的膜磷脂酰丝氨酸是将前体转化为活性形式所必需的。此外,血浆中的前体分子可以被野生型重组 RP S19 取代,但不能被其突变形式取代。这些结果表明,血浆中存在与 RP S19 不可区分的分子,并且该 RP S19 样分子通过包括暴露于磷脂酰丝氨酸的血小板膜的支架上的转谷氨酰胺酶催化反应转化为活性形式。